Comments
The World Trade Organization’s TRIPS Council (a multi-lateral agreement on intellectual property) is meeting right now to discuss a proposal from India and other developing nations to extend the waiver intellectual property rights for Covid diagnostics and therapeutics. The deadline to reach a decision – that is, to provide a waiver and to what extent -- is December 17, but would they meet it?
In this podcast, let us find out why does India and other developing countries want intellectual property waiver extensions. Why are developed countries not agreeing to it? What can we expect from the latest TRIPS Council informal meetings? Listen in.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.